Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)-Reference-Cited by-同舟云学术

Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

Published:2019-11-21 Issue:2 Volume:105 Page:297-316
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Yakoub-Agha Ibrahim,Chabannon Christian,Bader Peter,Basak Grzegorz W.,Bonig Halvard,Ciceri Fabio,Corbacioglu Selim,Duarte Rafael F.,Einsele Hermann,Hudecek Michael,Kersten Marie José,Köhl Ulrike,Kuball Jürgen,Mielke Stephan,Mohty Mohamad,Murray John,Nagler Arnon,Robinson Stephen,Saccardi Riccardo,Sanchez-Guijo Fermin,Snowden John A.,Srour Micha,Styczynski Jan,Urbano-Ispizua Alvaro,Hayden Patrick J.,Kröger Nicolaus

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 246 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic toxicity of CAR-T therapy and potential monitoring indicators for toxicity prevention;Frontiers in Immunology;2024-08-26

2. Comparing the Differences in Adverse Events among Chimeric Antigen Receptor T-Cell Therapies: A Real-World Pharmacovigilance Study;Pharmaceuticals;2024-08-05

3. Biomarkers of outcome in patients undergoing CD19 CAR‐T therapy for large B cell lymphoma;HemaSphere;2024-08

4. Advancements in Personalized CAR-T Therapy: Comprehensive Overview of Biomarkers and Therapeutic Targets in Hematological Malignancies;International Journal of Molecular Sciences;2024-07-15

5. Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies;Transplantation and Cellular Therapy;2024-07